Cargando…

Successful reduction of intraventricular asynchrony is associated with superior response to cardiac resynchronization therapy

BACKGROUND: Cardiac resynchronization therapy (CRT) is generally associated with a low to moderate increase of the left ventricular ejection fraction (LVEF). In some patients, however, LVEF improves remarkably and reaches near-normal values. The aim of the present study was to further characterize t...

Descripción completa

Detalles Bibliográficos
Autores principales: Dreger, Henryk, Borges, Adrian C, Baumann, Gert, Melzer, Christoph
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2944148/
https://www.ncbi.nlm.nih.gov/pubmed/20809960
http://dx.doi.org/10.1186/1476-7120-8-35
_version_ 1782187082100244480
author Dreger, Henryk
Borges, Adrian C
Baumann, Gert
Melzer, Christoph
author_facet Dreger, Henryk
Borges, Adrian C
Baumann, Gert
Melzer, Christoph
author_sort Dreger, Henryk
collection PubMed
description BACKGROUND: Cardiac resynchronization therapy (CRT) is generally associated with a low to moderate increase of the left ventricular ejection fraction (LVEF). In some patients, however, LVEF improves remarkably and reaches near-normal values. The aim of the present study was to further characterize these so called 'super-responders' with a special focus on the extent of intra- and interventricular asynchrony before and after device implantation compared to average responders. METHODS: 37 consecutive patients who underwent CRT device implantation according to current guidelines were included in the study. Patients were examined by echocardiography before, one day after and six months after device implantation. Pre-defined criterion for superior response to CRT was an LVEF increase > 15% after six months. RESULTS: At follow-up, eight patients (21.6%) were identified as super-responders. There were no significant differences regarding age, gender, prevalence of ischemic heart disease and LVEF between average and super-responders at baseline. After six months, LVEF had significantly increased from 26.7% ± 5.7% to 33.1% ± 7.9% (p < 0.001) in average and from 24.0% ± 6.7% to 50.3% ± 7.4% (p < 0.001) in super-responders. Both groups showed a significant reduction of QRS duration as well as LV end-diastolic and -systolic volumes under CRT. At baseline, the interventricular mechanical delay (IVMD) was 53.7 ± 20.9 ms in average and 56.9 ± 22.4 ms in super-responders - representing a similar extent of interventricular asynchrony in both groups (p = 0.713). CRT significantly reduced the IVMD to 20.3 ± 15.7 (p < 0.001) in average and to 19.8 ± 15.9 ms (p = 0.013) in super-responders with no difference between both groups (p = 0.858). As a marker for intraventricular asynchrony, we assessed the longest intraventricular delay between six basal LV segments. At baseline, there was no difference between average (86.2 ± 30.5 ms) and super-responders (78.8 ± 23.6 ms, p = 0.528). CRT significantly reduced the longest intraventricular delay in both groups - with a significant difference between average (66.2 ± 36.2 ms) and super-responders (32.5 ± 18.3 ms, p = 0.022). Multivariate logistic regression analysis identified the longest intraventricular delay one day after device implantation as an independent predictor of superior response to CRT (p = 0.038). CONCLUSIONS: A significant reduction of the longest intraventricular delay correlates with superior response to CRT.
format Text
id pubmed-2944148
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29441482010-09-24 Successful reduction of intraventricular asynchrony is associated with superior response to cardiac resynchronization therapy Dreger, Henryk Borges, Adrian C Baumann, Gert Melzer, Christoph Cardiovasc Ultrasound Research BACKGROUND: Cardiac resynchronization therapy (CRT) is generally associated with a low to moderate increase of the left ventricular ejection fraction (LVEF). In some patients, however, LVEF improves remarkably and reaches near-normal values. The aim of the present study was to further characterize these so called 'super-responders' with a special focus on the extent of intra- and interventricular asynchrony before and after device implantation compared to average responders. METHODS: 37 consecutive patients who underwent CRT device implantation according to current guidelines were included in the study. Patients were examined by echocardiography before, one day after and six months after device implantation. Pre-defined criterion for superior response to CRT was an LVEF increase > 15% after six months. RESULTS: At follow-up, eight patients (21.6%) were identified as super-responders. There were no significant differences regarding age, gender, prevalence of ischemic heart disease and LVEF between average and super-responders at baseline. After six months, LVEF had significantly increased from 26.7% ± 5.7% to 33.1% ± 7.9% (p < 0.001) in average and from 24.0% ± 6.7% to 50.3% ± 7.4% (p < 0.001) in super-responders. Both groups showed a significant reduction of QRS duration as well as LV end-diastolic and -systolic volumes under CRT. At baseline, the interventricular mechanical delay (IVMD) was 53.7 ± 20.9 ms in average and 56.9 ± 22.4 ms in super-responders - representing a similar extent of interventricular asynchrony in both groups (p = 0.713). CRT significantly reduced the IVMD to 20.3 ± 15.7 (p < 0.001) in average and to 19.8 ± 15.9 ms (p = 0.013) in super-responders with no difference between both groups (p = 0.858). As a marker for intraventricular asynchrony, we assessed the longest intraventricular delay between six basal LV segments. At baseline, there was no difference between average (86.2 ± 30.5 ms) and super-responders (78.8 ± 23.6 ms, p = 0.528). CRT significantly reduced the longest intraventricular delay in both groups - with a significant difference between average (66.2 ± 36.2 ms) and super-responders (32.5 ± 18.3 ms, p = 0.022). Multivariate logistic regression analysis identified the longest intraventricular delay one day after device implantation as an independent predictor of superior response to CRT (p = 0.038). CONCLUSIONS: A significant reduction of the longest intraventricular delay correlates with superior response to CRT. BioMed Central 2010-09-01 /pmc/articles/PMC2944148/ /pubmed/20809960 http://dx.doi.org/10.1186/1476-7120-8-35 Text en Copyright ©2010 Dreger et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Dreger, Henryk
Borges, Adrian C
Baumann, Gert
Melzer, Christoph
Successful reduction of intraventricular asynchrony is associated with superior response to cardiac resynchronization therapy
title Successful reduction of intraventricular asynchrony is associated with superior response to cardiac resynchronization therapy
title_full Successful reduction of intraventricular asynchrony is associated with superior response to cardiac resynchronization therapy
title_fullStr Successful reduction of intraventricular asynchrony is associated with superior response to cardiac resynchronization therapy
title_full_unstemmed Successful reduction of intraventricular asynchrony is associated with superior response to cardiac resynchronization therapy
title_short Successful reduction of intraventricular asynchrony is associated with superior response to cardiac resynchronization therapy
title_sort successful reduction of intraventricular asynchrony is associated with superior response to cardiac resynchronization therapy
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2944148/
https://www.ncbi.nlm.nih.gov/pubmed/20809960
http://dx.doi.org/10.1186/1476-7120-8-35
work_keys_str_mv AT dregerhenryk successfulreductionofintraventricularasynchronyisassociatedwithsuperiorresponsetocardiacresynchronizationtherapy
AT borgesadrianc successfulreductionofintraventricularasynchronyisassociatedwithsuperiorresponsetocardiacresynchronizationtherapy
AT baumanngert successfulreductionofintraventricularasynchronyisassociatedwithsuperiorresponsetocardiacresynchronizationtherapy
AT melzerchristoph successfulreductionofintraventricularasynchronyisassociatedwithsuperiorresponsetocardiacresynchronizationtherapy